{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T22:19:05Z","timestamp":1773699545974,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T00:00:00Z","timestamp":1248825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>Our team previously demonstrated that diabetes induces a deterioration in vascular dynamics, in parallel with the enhanced formation of advanced glycation end products. The aim of this study was to determine whether prevention of the arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>Diabetes was induced in rats by a single tail vein injection with 55\u2003mg\u00b7kg<jats:sup>\u22121<\/jats:sup>steptozotocin (STZ). After induction of hyperglycaemia, animals were treated for 8 weeks with pyridoxamine (1\u2003g\u00b7L<jats:sup>\u22121<\/jats:sup>in drinking water) and compared with the age\u2010matched untreated diabetic controls. Pulse wave reflection along the vasculature was derived using the impulse response function of the filtered aortic input impedance spectra.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>Treatment of this experimental diabetes with pyridoxamine resulted in a significant increase in wave transit time and a decrease in wave reflection factor, indicating that pyridoxamine attenuates the diabetes\u2010induced augmentation in systolic load of the left ventricle coupled to its arterial system. Meanwhile, pyridoxamine therapy ameliorated the diabetes\u2010related cardiac hypertrophy, as evidenced by the reduction in ratio of the left ventricular weight to body weight. Glycation\u2010derived modification of aortic collagen was also found to be attenuated by administration of pyridoxamine to the STZ\u2010induced diabetic rats.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>Pyridoxamine imparts significant protection against the diabetes\u2010induced deterioration in pulsatile arterial load imposed on the heart, at least partly through inhibition of the formation of advanced glycation end products and their accumulation on aortic collagen of the STZ\u2010treated rats.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00309.x","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T17:25:35Z","timestamp":1248888335000},"page":"1419-1426","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen"],"prefix":"10.1111","volume":"157","author":[{"given":"Kuo\u2010Chu","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin\u2010Tung","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei\u2010Shan","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming\u2010Shiou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan\u2010Lih","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,29]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2006.00595.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx0300535"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.1.1"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1615"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198805193182007"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.1997.sp004028"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/153537020322800110"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706684"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1974.36.3.381"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.6.918"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M305099200"},{"key":"e_1_2_8_13_1","first-page":"652A","article-title":"Pharmacokinetics, tolerability and biologic activity of oral pyridorin\u2122, a novel age inhibitor, in patients with type 1 diabetes and diabetic nephropathy","volume":"13","author":"Degenhardt TP","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(98)00343-5"},{"key":"e_1_2_8_15_1","first-page":"115","volume-title":"Human Physiology and Mechanisms of Disease","author":"Guyton AC","year":"1992"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2337\/diab.43.12.1450","article-title":"Active and passive mechanical properties of isolated arterioles from STZ\u2010induced diabetic rats. Effect of aminoguanidine treatment","volume":"43","author":"Hill MA","year":"1994","journal-title":"Diabetes"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116716"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1109\/TBME.1978.326244"},{"key":"e_1_2_8_19_1","first-page":"H588","article-title":"Estimation of total arterial compliance: an improved method and evaluation of current methods","volume":"251","author":"Liu A","year":"1986","journal-title":"Am J Physiol"},{"key":"e_1_2_8_20_1","volume-title":"Hemodynamics","author":"Milnor WR","year":"1989"},{"key":"e_1_2_8_21_1","first-page":"H1907","article-title":"Measurement of aortic input impedance in rats","volume":"267","author":"Mitchell GF","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9861(02)00067-X"},{"key":"e_1_2_8_23_1","volume-title":"McDonald's Blood Flow in Arteries","author":"Nichols WW","year":"2005"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-8634-6_1"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051140"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)02360-7"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051591"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0592-68"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.501"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e3282f4e539"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.428"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450054021873"},{"key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2337\/diab.42.2.221","article-title":"Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end\u2010product formation","volume":"42","author":"Tilton RG","year":"1993","journal-title":"Diabetes"},{"key":"e_1_2_8_34_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0031-6997(25)00059-6","article-title":"Functional consequences of streptozotocin\u2010induced diabetes mellitus, with particular reference to the cardiovascular system","volume":"44","author":"Tomlinson KC","year":"1992","journal-title":"Pharmacol Rev"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.1999.122"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5082-7"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109935200"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307155200"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/6.6.648"},{"key":"e_1_2_8_40_1","first-page":"7A","article-title":"A phase 2 clinical trial of pyridoxamine (Pyridorin\u2122) in type 1 and type 2 diabetic patients with overt nephropathy (PYR\u2010206)","volume":"14","author":"Williams ME","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90719-9"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00309.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00309.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:05:11Z","timestamp":1739286311000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00309.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,29]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00309.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00309.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,29]]},"assertion":[{"value":"2009-07-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}